SFT — Sopharma Trading AD Cashflow Statement
0.000.00%
Last trade - 00:00- €104.86m
- €237.79m
- BGN2.30bn
Annual cashflow statement for Sopharma Trading AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -82.2 | -82.5 | -93.3 | -119 | -147 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -173 | 18.6 | 48 | 68.8 | -4.16 |
| Capital Expenditures | -12.8 | -9.23 | -14.8 | -18.6 | -21.6 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.51 | -2.92 | -11 | -9.84 | 0.386 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -14.3 | -12.1 | -25.8 | -28.4 | -21.2 |
| Financing Cash Flow Items | 193 | 30.5 | 0.331 | -0.085 | -0.002 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 192 | -11.3 | -15.9 | -39.8 | 27 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.42 | -4.86 | 6.28 | 0.567 | 1.68 |